Cyprotex PLC (Cyprotex) is a United Kingdom-based holding company. The Company is engaged in providing in vitro and in silico ADMET and PK (Absorption, Distribution, Metabolism, Excretion, Toxicity and Pharmacokinetics) information to various industries including the pharmaceutical, biotechnology, cosmetic, personal care, agrochemical, chemical industries and academia. The Company�s trading subsidiaries are Cyprotex Discovery Limited and Cyprotex US, LLC (formerly Apredica LLC. Cyprotex provides a range of ADME Tox contract research services, which includes ADME screening, Customized ADME assays, Genomic ADME, In silico pharmacokinetics modeling and In vitro toxicology. It also offers integrated drug discovery services in collaboration with Sygnature Discovery and physicochemical profiling services in collaboration with Sirius Analytical.